Therapeutic approaches to the control of cytomegalovirus infections.
D000212:Acyclovir / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000151:congenital / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D007231:Infant, Newborn; D007369:Interferon Inducers / Q000627:therapeutic use*; D007370:Interferon Type I / Q000627:therapeutic use*; D016030:Kidney Transplantation; D011183:Postoperative Complications / Q000628:therapy; D014740:Vidarabine / Q000627:therapeutic use*
D007369:Interferon Inducers; D007370:Interferon Type I; D014740:Vidarabine; D000212:Acyclovir